CIK 0000730272 · Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 042729386
- Phone
- 7814499560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 10-Q Report Quarterly Report
- 8-K Event Unregistered share sale · Other events
- 8-K Event Results of operations
- 4 Insider Changes in Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Insider Changes in Ownership
- 8-K Event Acquisition or sale completed · Regulation FD disclosure
- 144 Insider Sale of Securities
- 4 Insider Changes in Ownership
- 144 Insider Sale of Securities
- 425 Deal Prospectus/Communication re Business Combination
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 144 Insider Sale of Securities
- 4 Insider Changes in Ownership
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Other events
Page 1 of 69 · 1,379 filings